Compare CRNX & SSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRNX | SSL |
|---|---|---|
| Founded | 2008 | 1950 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.8B |
| IPO Year | 2018 | N/A |
| Metric | CRNX | SSL |
|---|---|---|
| Price | $48.27 | $6.43 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $71.00 | N/A |
| AVG Volume (30 Days) | ★ 992.2K | 718.1K |
| Earning Date | 11-06-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.59 |
| Revenue | $1,535,000.00 | ★ $14,028,282,389.00 |
| Revenue This Year | $425.41 | $0.47 |
| Revenue Next Year | $943.30 | $5.51 |
| P/E Ratio | ★ N/A | $10.65 |
| Revenue Growth | ★ 47.74 | N/A |
| 52 Week Low | $24.10 | $2.78 |
| 52 Week High | $54.18 | $7.39 |
| Indicator | CRNX | SSL |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 52.34 |
| Support Level | $43.04 | $6.09 |
| Resistance Level | $49.61 | $6.47 |
| Average True Range (ATR) | 2.04 | 0.13 |
| MACD | -0.16 | 0.03 |
| Stochastic Oscillator | 62.22 | 86.25 |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.